Evidence map›Paper›PMID 33532137›Full record

ReviewAging and disease2021

Pathogenesis and Management in Cerebrovenous Outflow Disorders.

Chaobo Bai, Zhongao Wang, Christopher Stone, Da Zhou, Jiayue Ding, Yuchuan Ding, Xunming Ji, Ran Meng

Open access · goldAbstract readReview
In one paragraph

Review in Aging and disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Normobaric Hyperoxia Therapy in Treating Stroke.Clinical interventions in aging · 2025
    Review
  7. Dehydration in cerebral venous sinus thrombosis.CNS neuroscience & therapeutics · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Chaobo Bai1Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Zhongao Wang1Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Christopher Stone4Department of Neurosurgery, Wayne State University School of Medicine, Detroit, Michigan, USA.
Da Zhou1Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Jiayue Ding1Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Yuchuan Ding3Department of China-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China.
Xunming Ji2Advanced Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.
Ran Meng1Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Capital Medical University · CNChinese Institute for Brain Research · CNWayne State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In keeping with its status as one of the major causes of disability and mortality worldwide, brain damage induced by cerebral arterial disease has been the subject of several decades of scientific investigation, which has resulted in a vastly improved understanding of its pathogenesis. Brain injury mediated by venous etiologies, however, such as cerebral, jugular, and vertebral venous outflow disturbance, have been largely ignored by clinicians. Unfortunately, this inattention is not proportional to the severity of cerebral venous diseases, as the impact they exact on the quality of life of affected patients may be no less than that of arterial diseases. This is evident in disease sequelae such as cerebral venous thrombosis (CVT)-mediated visual impairment, epilepsy, and intracranial hypertension; and the long-term unbearable head noise, tinnitus, headache, dizziness, sleeping disorder, and even severe intracranial hypertension induced by non-thrombotic cerebral venous sinus (CVS) stenosis and/or internal jugular venous (IJV) stenosis. In addition, the vertebral venous system (VVS), a large volume, valveless vascular network that stretches from the brain to the pelvis, provides a conduit for diffuse transmission of tumors, infections, or emboli, with potentially devastating clinical consequences. Moreover, the lack of specific features and focal neurologic signs seen with arterial etiologies render cerebral venous disease prone to both to misdiagnoses and missed diagnoses. It is therefore imperative that awareness be raised, and that as comprehensive an understanding as possible of these issues be cultivated. In this review, we attempt to facilitate these goals by systematically summarizing recent advances in the diagnosis and treatment of these entities, including CVT, CVS stenosis, and IJV stenosis, with the aim of providing a valid, practical reference for clinicians.

Indexed as

cerebral venous sinus stenosiscerebral venous thrombosisdiagnosisinternal jugular vein stenosistreatment

Identifiers

PMID33532137
PMCPMC7801276
OpenAlexW3119675598

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.